Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    NIAID | Open Studies | Exclude Unknown | anthrax OR botulism OR plague OR pox OR tularemia OR Viral hemorrhagic fever OR Junin OR Machupo OR Guanarito OR Lassa OR Hanta OR Rift Valley OR Dengue OR Ebola OR Marburg
Show Display Options
RSS Create an RSS feed from your search for:
NIAID | Open Studies | Exclude Unknown | anthrax OR botulism OR plague OR pox OR tularemia OR Viral hemorrhagic fever OR Junin OR Machupo OR Guanarito OR Lassa OR Hanta OR Rift Valley OR Dengue OR Ebola OR Marburg
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Safety and Immunogenicity of Prime-Boost VSV Ebola Vaccine in Healthy Adults
Condition: Ebola Viruses
Interventions: Other: Placebo;   Biological: BPSC1001
2 Recruiting Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients
Condition: Anthrax
Intervention:
3 Recruiting Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults
Condition: Healthy Adult Immune Responses to Vaccine
Interventions: Biological: VRC-EBOADC069-00-VP;   Biological: VRC-EBOADC076-00-VP
4 Recruiting Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine - Admixture TV003;   Biological: TetraVax-DV Vaccine - Admixture TV005;   Biological: Placebo
5 Recruiting Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults
Condition: Dengue
Interventions: Biological: TetraVax-DV-TV003;   Biological: rDEN2∆30-7169;   Biological: Placebo
6 Recruiting Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age
Condition: West Nile Virus
Interventions: Biological: WN/DEN4Δ30 Vaccine;   Biological: Placebo

Indicates status has not been verified in more than two years